The Biotech Hall of Shame

March 10, 2017

(Managed Care Magazine) – FierceBiotech has issued its picks for 2016’s nine worst biotech companies. The list presents a sobering panorama of deaths in clinical trials, falling share prices wiping out value and confidence, deal-making blunders, epic fails, trillion-dollar opportunities lost, and fundamental technology falling short.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.